In this episode of From Science to Strategy, we’re talking about how carbon emissions can be turned into valuable opportunities. We’ll break down innovative solutions like algae-based carbon capture and look at why some companies are missing out on huge potential by not adopting these methods.

We’ll also explore the numbers behind technologies like pyrolysis and ionothermal, and how they could change the way industries think about sustainability. Tune in—this could change the way you think about carbon and profit!

*PreScouter is at the forefront of AI adoption and is happy to present you this episode courtesy of our AI presenters from Google NotebookLM.

Join João Guerreiro, Technical Director at PreScouter, as he sits down with Dr. Madabushi, Assistant Professor of AI at the University of Bath. They’ll be tackling the big question: Can Large Language Models drive innovation? Tune in to hear their insights on the role of LLMs in shaping the future of innovation.

Welcome to another episode of From Science to Strategy by PreScouter! Today, we’re spotlighting the Top 10 Carbon Capture Projects of 2024, chosen through extensive analysis by our team. This year has been groundbreaking, with global CCS capacity growing by 15%—adding 55 million tons of CO₂ capture potential. With 628 projects worldwide, a 60% increase from 2023, the momentum is undeniable.
Let’s explore these groundbreaking projects and talk about the innovations shaping a carbon-neutral future.

*PreScouter is at the forefront of AI adoption and is happy to present you this episode courtesy of our AI presenters from Google NotebookLM.

In this episode of From Science to Strategy, we're talking about a revolutionary technology that's set to change the way we design, use, and repair products – debonding adhesives. It’s not just about glue; it’s about making products easier to repair and recycle, with a huge impact on everything from smartphones to electric vehicles. Curious how this technology is reshaping industries? Tune in to learn more about the future of repairable, sustainable products. 

In this episode of From Science to Strategy, we explore the dark genome – once considered junk but now emerging as pharma’s next billion-dollar bet in therapeutics. We’ll dive into how this overlooked part of our DNA is reshaping drug discovery, improving cancer and diabetes treatments, and why it's attracting significant attention from researchers and pharma companies. Tune in to discover how the dark genome is set to transform the future of medicine.

*PreScouter is at the forefront of AI adoption and is happy to present you this episode courtesy of our AI presenters from Google NotebookLM.